DUBLIN, Jan. 26, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/sg852q/patient_registry) has announced the addition of the "Patient Registry Software Market by Delivery Mode, Functionality, Database & by End User - Forecast to 2019" report to their offering.
A patient registry is a computerized database that uses observational study methods to collect and store patient information to evaluate specified outcomes for a population defined by a particular disease, condition, or drug/medical device exposure. Patient registries are focused on populations and designed to fulfill specific purposes defined before the data are collected and analyzed. This market is driven by several factors, including government initiatives for population health management across the globe, and the rising pressure on healthcare organizations to improve the quality of care and minimize healthcare costs and increase adoption of EHRs.
The rising adoption of subscription models, integrated patient registry software, and rare disease registries have opened an array of opportunities for the growth of the patient registry software market. However, data privacy and security concerns, lack of resources with cross-functional skills, and reluctance to adopt advanced systems are expected to restrain the growth of this market.
The patient registry software market size, in terms of value, is expected to reach $610.8 million by 2019 from $381.0 million in 2014 at a CAGR of 9.9%. The market is segmented on the basis of delivery model, product type, database type, functionality, end user, and region.
The market by delivery model is divided into subscription models and ownership models. The ownership models refer to the on-premise mode of delivery, while the subscription model covers web-hosted and cloud-based delivery modes. The subscription models segment is expected to hold the largest share of global patient registry market, by delivery model.
The patient registry software market, by product type, is divided into integrated and standalone software. The adoption rate of integrated software is higher as they are user-friendly and integrated with different functionalities, thereby reducing overall cost.
The market, by database type, is classified into diabetes, cardiovascular, cancer, rare disease, chronic, and other registries. The rare disease registries segment is poised to witness high growth due to the rising pool of patients for these diseases.
Key players in the market include Global Vision Technologies, Inc. (U.S.), ImageTrend, Inc. (U.S.), ifa systems AG (Germany), INC Research Holdings, Inc. (U.S.), McKesson Corporation (U.S.), Phytel, Inc. (U.S.), Quintiles Transnational Holdings, Inc. (U.S.), Optum, Inc. (U.S.), Telligen, Inc. (U.S.), and Velos, Inc. (U.S.), among others.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Patient Registry Software Market, By Delivery Model
8 Patient Registry Software Market, By Product Type
9 Patient Registry Software Market, By Database Type
10 Patient Registry Software Market, By Functionality
11 Patient Registry Software Market, By End User
12 Patient Registry Software Market, By Region
13 Competitive Landscape
14 Company Profiles
- Global Vision Technologies, Inc.
- IFA Systems AG
- Imagetrend, Inc.
- Inc Research Holdings, Inc.
- Mckesson Corporation
- Optum, Inc. (A Part of Unitedhealth Group, Inc.)
- Phytel, Inc.
- Quintiles Transnational Holdings, Inc.
- Telligen, Inc.
- Velos, Inc.
For more information visit http://www.researchandmarkets.com/research/sg852q/patient_registry
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets